abstract |
The present invention relates to compounds of formula I wherein R < 1 > is a ring and n is an integer from 1 to 8. The present invention also relates to the use of such compounds as a metabotropic glutamate receptor enhancer, in particular in the treatment of neurological and psychiatric disorders. (I) |